Genetic Diversity and Antimicrobial Drug Resistance of Serotype VI Group B Streptococcus, Canada

Genetic Diversity and Antimicrobial Drug Resistance of Serotype VI Group B Streptococcus, Canada

Two genetically dissimilar sequence type 1 clades dominate the serotype VI group B Streptococcus population of strains causing invasive disease in Canada. Isolates of this rare serotype, recovered mainly from adult patients, were all susceptible to penicillin and vancomycin. However, we observed res...

Full description

Bibliographic Details
Main Authors: Alefiya Neemuchwala, Sarah Teatero, Lindsay Liang, Irene Martin, Walter Demzcuk, Allison McGeer, Nahuel Fittipaldi
Format: Article
Language:English
Published: Centers for Disease Control and Prevention 2018-10-01
Series:Emerging Infectious Diseases
Subjects:
Streptococcus group B
Streptococcus agalactiae
genomics
genetic diversity
drug resistance
microbial
Online Access:https://wwwnc.cdc.gov/eid/article/24/10/17-1711_article

Internet

https://wwwnc.cdc.gov/eid/article/24/10/17-1711_article

Similar Items